Study #2018-0564
Feasibility of Monitoring Step Count as a Measure of Physical Activity in Patients with Newly Diagnosed Glioma Patients Undergoing Radiation Therapy
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This trial studies the feasibility of monitoring step count as a measure of physical activity in patients with newly diagnosed glioma undergoing radiation therapy. Physical activity measured by step count may help to improve the quality of life and symptoms for patients with newly diagnosed glioma.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Glioma;Radiation Therapy Patient
Study phase:
Not applicable
Physician name:
Shiao-Pei Weathers
Department:
Neuro-Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.